Orchestra BioMed Holdings (OBIO) Revenue (2022 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Revenue came in at $110000.0 in Q1 2026, down 87.33% year-on-year from $868000.0 in Q1 2025, and down 99.64% on a QoQ basis from $30.9 million in Q4 2025.
Orchestra BioMed Holdings (OBIO) Revenue (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 5 years of Revenue data on file, last reported at $110000.0 in Q1 2026.
- On a quarterly basis, Revenue fell 87.33% year-over-year to $110000.0 in Q1 2026; TTM through Mar 2026 was $32.7 million, a 1033.89% increase from a year earlier, with the FY2025 full-year figure at $33.5 million, up 1169.22% from the prior year.
- Revenue for Q1 2026 stood at $110000.0, down from $30.9 million in the prior quarter.
- Over the last five years, Revenue for OBIO reached as high as $30.9 million in Q4 2025 and fell as low as $110000.0 in Q1 2026.
- Historically, Revenue has averaged $2.5 million across 5 years, with a median of $861000.0 in 2025.
- Across the five-year window, Revenue surged 12120.16% in 2025 and tumbled 87.33% in 2026, its largest moves.
- Year by year, Revenue stood at $1.1 million in 2022, then sank by 76.25% to $262000.0 in 2023, then declined by 3.44% to $253000.0 in 2024, then jumped by 12120.16% to $30.9 million in 2025, then tumbled by 99.64% to $110000.0 in 2026.
- Per Business Quant data, the three most recent Revenue figures were $110000.0 in Q1 2026, $30.9 million in Q4 2025, and $861000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Orchestra BioMed Holdings | 235.83 Mn | 141.43 Mn | 78,000.00 | 110,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 110,000.00 |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 861,000.00 |
| Jun 30, 2025 | 836,000.00 |
| Mar 31, 2025 | 868,000.00 |
| Dec 31, 2024 | 253,000.00 |
| Sep 30, 2024 | 987,000.00 |
| Jun 30, 2024 | 778,000.00 |
| Mar 31, 2024 | 620,000.00 |
| Dec 31, 2023 | 262,000.00 |
| Sep 30, 2023 | 419,000.00 |
| Jun 30, 2023 | 915,000.00 |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 1.16 Mn |
| Jun 30, 2022 | 401,000.00 |
| Mar 31, 2022 | 866,000.00 |